119 related articles for article (PubMed ID: 1386277)
1. Role of 5-hydroxytryptamine receptors on luteinizing-hormone-releasing hormone release in the ovariectomized, estradiol-treated rat.
Meyer DC; McRee C; Jacobs M
Brain Res Bull; 1992 Jun; 28(6):853-60. PubMed ID: 1386277
[TBL] [Abstract][Full Text] [Related]
2. Serotonin stimulation of the period of in vitro LHRH release is estradiol dependent.
Meyer DC
Brain Res Bull; 1989 Mar; 22(3):525-30. PubMed ID: 2653571
[TBL] [Abstract][Full Text] [Related]
3. In-vitro pulsatile luteinizing hormone-releasing hormone output is dependent on hypothalamic region and the stage of the estrous cycle.
Meyer DC
Biol Reprod; 1987 Dec; 37(5):1207-14. PubMed ID: 3327540
[TBL] [Abstract][Full Text] [Related]
4. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
Tricklebank MD; Neill J; Kidd EJ; Fozard JR
Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
[TBL] [Abstract][Full Text] [Related]
5. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
Goodwin GM; Green AR
Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
[TBL] [Abstract][Full Text] [Related]
6. Involvement of 5-HT1A- and alpha 2-receptors in the decreased 5-hydroxytryptamine release and metabolism in rat suprachiasmatic nucleus after intravenous 8-hydroxy-2-(n-dipropylamino) tetralin.
Marsden CA; Martin KF
Br J Pharmacol; 1986 Oct; 89(2):277-86. PubMed ID: 2430656
[TBL] [Abstract][Full Text] [Related]
7. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
Hoyer D; Engel G; Kalkman HO
Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y stimulates the release of luteinizing hormone-releasing hormone from medial basal hypothalamus in vitro: modulation by ovarian hormones.
Crowley WR; Kalra SP
Neuroendocrinology; 1987 Aug; 46(2):97-103. PubMed ID: 3306435
[TBL] [Abstract][Full Text] [Related]
9. Release of endogenous aspartate from rat cerebellum slices and synaptosomes: inhibition mediated by a 5-HT2 receptor and by a 5-HT1 receptor of a possibly novel subtype.
Maura G; Barzizza A; Folghera S; Raiteri M
Naunyn Schmiedebergs Arch Pharmacol; 1991 Mar; 343(3):229-36. PubMed ID: 1830929
[TBL] [Abstract][Full Text] [Related]
10. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
11. In vitro gonadotropin-releasing hormone release from hypothalamic tissues of ovariectomized estrogen-treated cynomolgus macaques.
Levine JE; Bethea CL; Spies HG
Endocrinology; 1985 Jan; 116(1):431-8. PubMed ID: 3880545
[TBL] [Abstract][Full Text] [Related]
12. Serotonin-glutamate interaction in rat cerebellum: involvement of 5-HT1 and 5-HT2 receptors.
Maura G; Roccatagliata E; Ulivi M; Raiteri M
Eur J Pharmacol; 1988 Jan; 145(1):31-8. PubMed ID: 2965025
[TBL] [Abstract][Full Text] [Related]
13. 5-HT receptor-mediated regulation of thyrotropin-releasing hormone release in rat spinal cord.
Ono H; Ono SS; Fukuda H
Eur J Pharmacol; 1991 Oct; 203(2):283-5. PubMed ID: 1839283
[TBL] [Abstract][Full Text] [Related]
14. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
Chaouloff F; Jeanrenaud B
J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of corticosterone secretion by the selective 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the rat.
Przegaliński E; Budziszewska B; Warchoł-Kania A; Błaszczyńska E
Pharmacol Biochem Behav; 1989 Jun; 33(2):329-34. PubMed ID: 2530590
[TBL] [Abstract][Full Text] [Related]
16. 8-OH-DPAT and buspirone analogs inhibit the ketanserin-sensitive quipazine-induced head shake response in rats.
Yocca FD; Wright RN; Margraf RR; Eison AS
Pharmacol Biochem Behav; 1990 Jan; 35(1):251-4. PubMed ID: 2138331
[TBL] [Abstract][Full Text] [Related]
17. Evidence that 5-HT1A receptors are involved in the adrenaline-releasing effects of 8-OH-DPAT in the conscious rat.
Chaouloff F; Baudrie V; Laude D
Naunyn Schmiedebergs Arch Pharmacol; 1990 Apr; 341(4):381-4. PubMed ID: 1970616
[TBL] [Abstract][Full Text] [Related]
18. Morphological evidence that luteinizing hormone-releasing hormone neurons participate in the suppression by estradiol of pituitary luteinizing hormone secretion in ovariectomized rats.
King JC; Anthony EL; Damassa DA; Elkind-Hirsch KE
Neuroendocrinology; 1987 Jan; 45(1):1-13. PubMed ID: 3543719
[TBL] [Abstract][Full Text] [Related]
19. Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Evidence for opposing roles of 5-HT2 and 5-HT1A receptors.
Gudelsky GA; Koenig JI; Meltzer HY
Neuropharmacology; 1986 Dec; 25(12):1307-13. PubMed ID: 2951611
[TBL] [Abstract][Full Text] [Related]
20. Peripubertal development of noradrenergic stimulation of luteinizing hormone-releasing hormone neurosecretion in vitro.
Clough RW; Hoffman GE; Sladek CD
Brain Res; 1988 Apr; 446(1):121-32. PubMed ID: 3285962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
